분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2014-04-10 00:46:32 , Hit : 1916
 FDA grants priority review for ledipasvir/sofosbuvir


April 7, 2014


The FDA has granted a priority review to a new drug application for a combination of ledipasvir and sofosbuvir to treat chronic hepatitis C virus infection genotype 1, according to a press release from Gilead Sciences.


  
Gilead said the application includes expedited review of a fixed once-daily tablet combination of its 90 mg ledipasvir (LDV), a NS5A inhibitor, and 400 mg sofosbuvir (SOF), a polymerase inhibitor, to treat hepatitis C virus (HCV) in adults for 8 or 12 weeks. The combination’s safety and efficacy have yet to be determined.

Gilead submitted data from three phase 3 studies, ION-1, ION-2 and ION-3; treatment will be based on patients’ prior treatment histories for HCV and whether they have cirrhosis, according to the release.

The FDA also has assigned LDV/SOF breakthrough therapy designation, which gives priority review status to medicines that may offer major treatment advances. A marketing application for LDV/SOF is under review by the European Commission and was validated by the European Medicines Agency in March 2014.

The FDA approved SOF (Sovaldi) in December 2013, and the European Commission gave its OK in January.







867   실험쥐가 남성 연구자로부터 받는 스트레스?  이성욱 2014/05/02 2126
866   세계의 과학자들, 성인의 세포를 이용해 배아줄기세포를 만드는 데 잇달아 성공  이성욱 2014/04/30 1573
865   백신 개발을 위한 HIV의 취약 부위의 발견  이성욱 2014/04/30 1629
864   다운 증후군과 백혈병 사이의 연관성을 밝혀주는 연구 결과  이성욱 2014/04/24 2098
863   다시 뛰는 RNAi: 10억 달러 들여 신약 개발, 150가지 요법 임상시험  이성욱 2014/04/24 2791
862   Anti-viral regimen to treat adults with HCV awaits FDA approval  이성욱 2014/04/24 1437
861   Tales of Aptamer Selection: Astute Observation and Thoughtful Experimentation or Serendipity?  이성욱 2014/04/23 2497
860   암 줄기세포의 항암제 저항성과의 연관성  이성욱 2014/04/23 2313
859   CTLA-4 항체의 항암 효과를 높이는 새로운 혼합치료  이성욱 2014/04/21 2102
858   난자와 정자의 결합을 가능하게 하는 단백질 발견  이성욱 2014/04/21 2067
857   HPV가 만든 인간 유전체의 고리가 암으로 진행  이성욱 2014/04/21 1906
856   First Patent Issued on CRISPR-Cas9  이성욱 2014/04/18 2005
855   왜 여성은 남성보다 더 알츠하이머 질환에 취약한가?  이성욱 2014/04/16 1897
854   트라우마의 추억 - 트라우마의 표지를 운반하는 정자의 miRNA  이성욱 2014/04/16 1921
853   Bristol-Myers hepatitis C treatment cures up to 90 pct -study  이성욱 2014/04/12 1601
852   Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy  이성욱 2014/04/11 1820
851   나쁜 환경의 스트레스가 텔로미어 길이 단축할까  이성욱 2014/04/11 2284
  FDA grants priority review for ledipasvir/sofosbuvir  이성욱 2014/04/10 1916
849   일본 STAP 세포연구의 세포주 불일치 발견과 조사위원회의 과학적 위법행위 발표  이성욱 2014/04/03 2017
848   STAP 논문, 결국 62일 만에...  이성욱 2014/04/02 1658

[이전 10개] [1].. 21 [22][23][24][25][26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN